The Speed of Money

Wow! Either it's an odd coincidence, or the Latisse marketers are highly vigilant monetizers, because in less than 24 hours after I posted yesterday's rambling little piece about the eyelash wonder drug, a tasteful little ad for it showed up on the Scienceblogs homepage (cue spooky music now). Robot voice: "Oh yes, I will go buy Latisse now." I will try it on my cats, because I have always thought that cats with long eyelashes are wickedly beautiful.

But, Latisse, your ad says "ask your doctor about Latisse" -- I'm a bit disappointed. How could you pass up such a ripe possibility for pun-itization: i.e. "see your doctor about Latisse today".

Actually, ever since Warner music went in and hatcheted all of its songs out of youtube videos, I've believed that monetizing is the more rational business approach. Latisse, you are so lusciously poofy, and yet so business savvy too. Awesome.

PS: I'm guessing it almost certainly was SEED who initiated the monetizing, but the image of a bunch of people with great eyelashes vigilantly searching the web for mentions of Latisse is just so wonderful.

More like this

The existence of the drug Latisse is clearly a harbinger of the end of modern civilization, in more ways than one, but it is also intensely fascinating and creepy. When I first heard of it, about a year ago, I really thought it was some sort of satirical article about the current status of big…
I am running out of eyelash puns having written at least six posts since the summer of 2007 on a class of anti-glaucoma drugs that have been harnessed for their cosmetic side effect: promotion of eyelash growth. Bimatoprost (Lumigan®) and latanoprost (Xalatan®) are members of the prostamide class…
The tagline is from Elaine D'Farley at Self magazine talking about the FDA's then-pending approval of Allergan's Latisse™ for cosmetic growth of longer, thicker eyelashes treatment of hypotrichosis of the eyelashes. While not expected until early 2009, Jacob Goldstein at the WSJ Health Blog clued…
Even at this incredibly slow time of the year for blog traffic, we hit about 250% of our average readership yesterday with search engines finding our post on Allergan's new eyelash enhancing cosmeceutical, Latisse. Lots of folks wanting to know where to buy Latisse - Allergan stock anyone? (Aside…